Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Bank Systems & Technology September 2, 2010 Katherine Burger	Paul Johnson of BB&T: Transformation Never Ends Nearing completion of a program to overhaul the way his technology organization operates and how it is viewed by the business, BB&T EVP and CIO Paul Johnson says the evolution of IT is an ongoing journey.
Bank Director 3rd Quarter 2009 John R. Engen	Capitalizing on Opportunities BB&T Corp. calls itself a "fast follower" -- a player that doesn't try to get there first with technology, but takes advantage of every smart play.
Bank Systems & Technology August 18, 2008 Lisa Valentine	Comerica EVP and CIO John Beran Balances IT and Operations A conversation with John Beran, who has the dual responsibility for operations and IT at Dallas-based Comerica.
Bank Systems & Technology May 24, 2007 Lisa Valentine	Union Bank of California's Jim Yee Is Reengineering Banking With A Customer Focus Union Bank of California's Jim Yee talks about the bank's reengineering process, IT budget and technology changes.
Bank Systems & Technology December 1, 2006 Thomas Kunz	Keeping Payments Relevant As PNC Financial Services Group's SVP and director of payments strategies, Thomas Kunz says it is his responsibility to deliver relevant technology solutions to customers in that rapidly changing environment.
The Motley Fool July 31, 2007 Nathan Parmelee	Break Out the Band-Aids at J&J Johnson & Johnson is making some deep cuts to change its cost structure. Shareholders haven't had much to cheer about lately here, but the potential benefits from this move could help cure some of the current softness in the business.
The Motley Fool June 4, 2010 Brian Orelli	Out With Drugs, in With Medical Devices Johnson & Johnson's movement in medical devices and diagnostics is headed in the right direction, but whether Johnson & Johnson is a buy depends a lot on how it handles its current drug problem. Unfortunately investors can't have one without the other.
The Motley Fool May 26, 2010 Brian Orelli	Is Johnson & Johnson a Buy? Let's see what it says to Congress first on safety issues.
The Motley Fool December 15, 2005 Stephen D. Simpson	BB&T Gets Crunk Buying Main Street Bank will expand this high-quality bank's footprint in the fast-growing Atlanta area. But the stock still isn't at my target price for a buy.
The Motley Fool July 14, 2008 Brian Orelli	Foolish Forecast: J&J Trudges Along In advance of earnings analysts wonder if Johnson & Johnson is a recovery story waiting to happen, or still stuck in a rut?
Bank Systems & Technology July 22, 2007 Lisa Valentine	Northern Trust's Jana Schreuder Discusses The Challenges of Growth and Globalization The bank focuses on keeping its two distinct businesses -- institutional and private wealth management -- integrated and in lockstep with the organization's strategic direction while dealing with the challenges presented by growth and globalization.
The Motley Fool January 18, 2012	What Johnson & Johnson Does With Its Cash Over the last five years, Johnson & Johnson shares returned 14%, which drops to -3% without dividends -- not a bad boost to top off otherwise lowly share performance.
The Motley Fool November 26, 2010 Brian Orelli	Get It Together, Johnson & Johnson Another day, another recall.
Bank Systems & Technology July 28, 2006	Joseph Antonellis Has Played a Role in Making State Street Corp. the World's Largest Investment Manager of Institutional Assets Focusing on technological innovations and forcing the business side to collaborate with IT has helped this EVP and CIO make State Street Corp. a success within the institutional investment community.
Bank Systems & Technology July 1, 2005 Steven Marlin	Banking for the 21st Century Since launching one of the first Internet banking sites 10 years ago, Salem Five Bank continually has melded technology to meet changing business requirements. Here's an interview with the firm's senior vice president of e-commerce on overcoming technology challenges.
The Motley Fool September 30, 2009 Brian Orelli	Boston Scientific Pays Up And Johnson & Johnson reaps the rewards.
Bank Systems & Technology August 4, 2004 Cynthia Ramsaran	Winning With Technology Tim Shack, chief information officer, PNC, offers insights on addressing customer needs.
The Motley Fool June 23, 2010 Brian Orelli	Duo of Diabetes Drug Deals Make J&J Better Licensing deals add to Johnson & Johnson's diabetes franchise.
Bank Systems & Technology July 28, 2010 Penny Crosman	Q&A: Martin Zorn, CAO, Tennessee Commerce Bank, on Dodd-Frank and on Building New Mobile Banking Apps To prepare for new regulations, this CAO is analyzing IT and other departments for places to squeeze efficiency out of the system.
Bank Systems & Technology April 28, 2008 Lisa Valentine	The Bank of New York Mellon Integrates Legacy Systems to Offer Customers Only the Best Following the merger of The Bank of New York and Mellon Financial, cohead of treasury services integration efforts Al Briand forges a best-of-breed and technology portfolio while continuing to provide Treasury Services customers with innovative new products.
The Motley Fool June 28, 2011 Eric Bleeker	Johnson & Johnson Is Looking Abroad for Growth Where's Johnson & Johnson generating its sales?
Bank Systems & Technology March 31, 2005 Steven Marlin	Engineering Change HVB Americas spent the past five years implementing a new technology architecture that integrates business process and data flow.
Bank Systems & Technology May 25, 2006 Lisa Valentine	When Clients Speak, Wells Fargo Listens An interview with Danny Peltz, EVP of Wells Fargo's Wholesale Internet and Treasury Solutions Group about the bank's commitment to delivering commercial customers a one-stop source for Internet banking services and products.
Bank Systems & Technology January 1, 2007 Lisa Valentine	The Right Technology at the Right Time and Price An interview with Greg Carmichael, who left the manufacturing sector to join Fifth Third Bancorp as CIO, on how he is focused on taking everything he's learned as CIO and applying those lessons to drive more value for customers and grow the firm.
The Motley Fool July 12, 2011 Todd Wenning	What Does Johnson & Johnson Do With Its Free Cash? Johnson & Johnson appears to be making fair use of its free cash flow, and its well-covered dividend may be attractive to income-focused investors.
The Motley Fool October 6, 2009 Jennifer Schonberger	This Is How We Should Fix the Financial System Economist Simon Johnson says a decision about regulating derivatives was the defining event.
Bank Systems & Technology June 24, 2008 Lisa Valentine	Peter Makohon Keeps Wachovia Secure on the Cyber Front Lines Wachovia's VP of information security says protecting the bank's network against ever more sophisticated attacks is a constant challenge that requires eternal vigilance.
Bank Systems & Technology July 25, 2008 Nancy Feig	BB&T Taps Software Earnings' Payments Navigator to Streamline Check and Item Processing Helping accommodate the industry's shift from paper to electronic payments, this solution enables banks to consolidate item processing sites and centralize all major item processing functions.
The Motley Fool January 23, 2008 Brian Orelli	A Dose of Stability From J&J Top-line growth looked great at Johnson & Johnson -- more than 16% year over year -- but when you dove a little further into the earnings, growth wasn't quite that stellar.
The Motley Fool November 28, 2008 Brian Orelli	The FDA's Killing Bug Killers Unfortunately for Johnson & Johnson and Swiss drugmaker Basilea Pharmaceutica, the FDA appears a little reluctant to take some of the data for the drugmakers' antibiotic ceftobiprole at face value.
The Motley Fool September 28, 2009 Brian Orelli	The Berkshire of Health Care Johnson & Johnson is becoming the Berkshire Hathaway of health care. In addition to its usual M.O. of bolt-on acquisitions, the health-care giant has recently taken some equity stakes in smaller drug companies.
Bank Systems & Technology August 30, 2005 Steven Marlin	Electronic Trading Increases Tech Demands An interview with Banc of America Securities (BAS) managing director Rob Flatley on how electronic trading developments, such as algorithmic trading, are increasing demands on banks' technology infrastructures.
Bank Systems & Technology July 21, 2010 Penny Crosman	Q&A: Brian Ware, SVP Compliance at FNCB, on How Dodd-Frank Will Affect Bank IT Departments The law will place a greater administrative burden on banks, accelerate their online projects and automation of account opening, and perhaps cause more risk because of that, Ware believes. The silver lining: the bill should provide job security for compliance experts.
The Motley Fool May 28, 2010 Brian Orelli	How Much Is This Going to Cost J&J? Investors need an answer from Johnson & Johnson about low-quality drugs that were recalled. Is the problem systemic, and if so, how much will it cost the company to fix the problem?
The Motley Fool February 23, 2009 Brian Orelli	The DOJ v. Johnson & Johnson The U.S. Department of Justice is joining a lawsuit against the health care giant over the company's marketing of heart failure drug Natrecor.
The Motley Fool August 27, 2010 Brian Orelli	A Recall a Week, That's All We Ask For Johnson & Johnson, apparently that's too much.
The Motley Fool February 26, 2007 Tim Beyers	Fool on the Street: Healthy Heinz Apparently, selling health is healthy for business. But organic innovation isn't the most important factor in going global. Investors, take note.
The Motley Fool October 12, 2004 Alyce Lomax	Take It Away, J&J Should investors sweat a coming slowdown in growth for pharmaceutical and consumer products giant Johnson & Johnson?
The Motley Fool October 14, 2008 Brian Orelli	Johnson & Johnson, Heal Thyself When your brother falls, you've got to pick up the pace.
The Motley Fool May 20, 2009 Brian Orelli	Johnson & Johnson Tries to Pull a Travolta Johnson & Johnson seems to be making a comeback, after its drug-eluting stent market share fell precipitously to just 15% in the first quarter.
The Motley Fool August 14, 2007 Brian Orelli	A No-Win Situation Johnson & Johnson is suing the beloved American Red Cross for trademark infringement. Johnson & Johnson just needs to walk a fine line between having its brand eroded by the Red Cross and having its brand eroded by a public relations nightmare.
The Motley Fool September 14, 2007 Brian Orelli	J&J's Expensive RNA Purchase Johnson & Johnson sets up a collaboration with Isis Pharmaceuticals to develop compounds to treat diabetes. Investors take note.
The Motley Fool December 1, 2010 Brian Orelli	We're Still Buying. Probably. Despite manufacturing problems, Johnson &Johnson continues with its purchase of Crucell.
Bank Systems & Technology November 4, 2003 Katherine Burger	Channel Strategies On a Massive Scale As EVP, technology solutions, for Inovant, the information technology and processing services subsidiary of Visa International, Scott Thompson is focused on critical issues such as transaction volume, speed and reliability, security, and support of newer business initiatives.
The Motley Fool June 25, 2010 Brian Orelli	The Joys of Being Large and Diversified Johnson & Johnson's plant closure is a rounding error.
The Motley Fool January 26, 2010 Brian Orelli	Is the Best of Johnson & Johnson Behind It? Johnson & Johnson announces that its sales fell for the first time in 76 years.
Bank Systems & Technology May 6, 2004 Cynthia Ramsaran	2004 Fed Forecast: Enhanced Electronic Payments Claudia S. Swendseid, SVP of the Fed's Financial Services Policy Committee, spoke about the organization's goals for 2004 and what it is currently doing to move the financial services industry gracefully from paper to electronic checks.
Bank Systems & Technology August 1, 2007 Lisa Valentine	Citi's Chief Data Officer Turns Data Into a Business Asset In this interview, the industry's first chief data officer and Citi's COO discuss how they are turning the firm's data into a business asset.
The Motley Fool October 19, 2010 Brian Orelli	Watch a 40% Decline Disappear The greatest thing going for Johnson & Johnson is its diversity in product offerings.
The Motley Fool October 19, 2011 Brian Orelli	Not the Best Quarter, but... There's little reason to worry about Johnson & Johnson.